1. Introduction {#sec1}
===============

DNA is always under constant threats and attacks from entities of endogenous or exogenous nature, which makes DNA repair response a crucial mechanism in all living beings. Nucleotide excision repair (NER) is one such DNA repair pathway that addresses bulky DNA damages, such as cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4PP), and helix-distorting platinum (Pt) cross-links, which are inflicted upon DNA by various mutagens.^[@ref1]−[@ref3]^ This process is mediated in a multistep fashion by the coordinated interaction of more than 20 different proteins, which is mainly overseen and systematized by *Xeroderma pigmentosum* complementation group A (XPA) protein, earning itself a title of "scaffolding protein". XPA functions as a primary damage recognition protein in both global genome NER (GG-NER) and transcription-coupled NER (TC-NER).^[@ref3]−[@ref7]^ As a result, any alteration in the XPA gene or in the protein function leads to classical *Xeroderma pigmentosum* (XP) disease that is characterized by extreme sun sensitivity, neurological damages, and is often linked with skin cancers.^[@ref4],[@ref6],[@ref8]−[@ref18]^

The highly conserved XPA,^[@ref19]−[@ref21]^ consisting of 273 residues,^[@ref22]^ with its disordered N- and C-terminals, has been reported to bind and interact with many proteins of NER as well as with the damaged DNA.^[@ref23]−[@ref25]^ The DNA-interacting region of XPA was mapped initially to the globular DNA-binding domain (DBD), which spans between 98 and 219 amino acid residues,^[@ref26],[@ref27]^ but since the earlier DBD lacked a significant amount of positive residues for the strong bonding with the negatively charged DNA, the DBD of XPA has been now redefined between 98 and 239 amino acid residues.^[@ref28]−[@ref30]^ To date, only a small number of the XPA's protein--protein interactions (PPI) with other NER proteins have been explored. Some of the well-documented PPIs of XPA are with (i) helicase, transcription factor II H (TFIIH) complex,^[@ref3],[@ref11],[@ref31]^ (ii) GG-NER damage verifier, *Xeroderma pigmentosum* complementation group C (XPC) protein,^[@ref32]−[@ref34]^ (iii) excision-repair cross-complementing group 1 endonuclease (*Xeroderma pigmentosum* group F) (ERCC1/XPF),^[@ref35]−[@ref37]^ and (iv) replication protein A70 (RPA70), which binds to the undamaged DNA.^[@ref7],[@ref27],[@ref38]^ For the remaining, unexplored set of PPIs between XPA and other NER proteins, only few binding sites of XPA by which it communicates with other NER proteins have been identified, whereas in some cases, vice versa, the binding site of the participating fellow NER proteins through which they interact with XPA is not known.

Among many such PPIs of XPA, one such interaction is with *Xeroderma pigmentosum* complementation group E, also known as the damaged DNA-binding protein 2 (DDB2/XPE), which is a subunit of the heterodimer DDB1/DDB2 protein complex, involved in damage verification and in the recognition of DNA lesions in GG-NER.^[@ref39]−[@ref41]^ In the earlier in vitro and in vivo studies by Wakasugi et al.,^[@ref42]^ the exact binding site of XPA through which it communicates with XPE was identified. They mapped out the exact binding range of XPA responsible for the interaction by conducting a series of N-terminal residue truncations of XPA in various residue lengths, before identifying its true binding location (aa185--226), which upon truncation anywhere in between the regions of the protein decreased the binding activity of these two proteins. They also reported a missense mutation in XPA, R207G, which lowered the chances of XPA's recruitment to the NER bubble. This particular mutation further inhibited the binding between XPA and XPE, leading to the incompetency on the part of NER to remove the CPD lesion from the DNA strand in simian vacuolating virus 40 (SV40) transformed human cells and thereby causing a complete NER failure. Since there is no structure for XPA--XPE complex, and the exact interaction site of XPA on XPE is not known either, it thus becomes important that the key residues mediating the binding of these two proteins be elucidated.

Therefore, in this study, we have attempted to determine the probable binding site of XPE to which XPA~185--226~ binds and analyze their PPI using the molecular dynamics (MD) approach, which is complementary to the experimental methods. Here, we prepared three models for the protein complex of XPA~185--226~--XPE using the ClusPro web server,^[@ref43]−[@ref45]^ followed by MD simulation of the systems using the Assisted Model Building with Energy Refinement (AMBER) 14 software package^[@ref46]^ to study their conformational dynamics and stability. Furthermore, using the molecular mechanics Poisson--Boltzmann surface area continuum solvation (MM-PBSA) package,^[@ref47]−[@ref51]^ we also identified the probable residues responsible for their stable protein formation using the per-residue energy decomposition (PRED) analysis.

2. Results {#sec2}
==========

2.1. Structural Modeling and the Validation of XPA~185--226~ Peptide, and the Selection of an Ideal Docked Model for XPA~185--226~--XPE Complex {#sec2.1}
-----------------------------------------------------------------------------------------------------------------------------------------------

The protein structure of XPA~185--226~ was obtained upon the submission of the protein's FASTA sequence to the Iterative Threading ASSEmbly Refinement (I-TASSER) server. We obtained a total of five models as shown in (Supporting Information [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf)) based on the threading program, out of which the best-ranked structure had a confidence score or C-score of 1.91, a template modeling (TM) score of 0.70 ± 0.12, and a root-mean-square deviation (RMSD) of 2.5 ± 1.9 Å. This structure was selected as our good fit model structure. A RAMPAGE analysis of this top-ranked modeled structure from I-TASSER showed that 100.0% of the residues were in the favored region and 0% were in the allowed region and disallowed region (Supporting Information [Figure S2A](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf)). The protein structure assessment (ProSA) web server scores the fitness of the modeled structures in the form of a Z-score after analyzing all of the atomic coordinates of the candidate model. The ProSA server houses the Z-scores of all of the structures that have been experimentally determined using NMR and X-ray crystallograpy and have been deposited in Protein Data Bank (PDB). If the Z-score of any modeled structure falls within these Z-scores of deposited PDB structures, then that modeled structure is said to have near-native structure conformation. The Z-score for our structure, XPA~185--226~, as seen in Supporting Information [Figure S2B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf), was −4.59, which indicated that our modeled structure is near to the native structure conformation. The final stereochemical quality of our model was analyzed using the MolProbity server, wherein our model was given the overall score of 0.89 (100th percentile). The detailed description scores for other attributes provided by the MolProbity server are shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. The analyses done by these three protein validation tools confirmed that our modeled structure is indeed a good fit model.

###### MolProbity Summary Statistics for the modeled XPA~185--226~ Protein[a](#t1fn1){ref-type="table-fn"}

  ------------------------------------------------------------------------------ ----------------------- ------------------------------------------- ------------------------------------------------- --------------------------------
  all-atom contacts                                                              clashscore, all atoms   1.36                                        99th percentile\* (*N* = 1784, all resolutions)   
  clashscore is the number of serious steric overlaps (\>0.4 Å) per 1000 atoms                                                                                                                         
  protein geometry                                                               poor rotamers           0                                           0.00%                                             goal: \<0.3%
  favored rotamers                                                               38                      97.44%                                      goal: \>98%                                       
  Ramachandran outliers                                                          0                       0.00%                                       goal: \<0.05%                                     
  Ramachandran favored                                                           40                      100.00%                                     goal: \>98%                                       
  MolProbity score^∧^                                                            0.87                    100th percentile\* (*N* = 27675, 0--99 Å)                                                     
  Cβ deviations \>0.25 Å                                                         0                       0.00%                                       goal: 0                                           
  bad bonds                                                                      0/360                   0.00%                                       goal: 0%                                          
  bad angles                                                                     1/474                   0.21%                                       goal: \<0.1%                                      
  peptide omegas                                                                 cis prolines            0/0                                         0.00%                                             expected: ≤1 per chain, or ≤5%
  ------------------------------------------------------------------------------ ----------------------- ------------------------------------------- ------------------------------------------------- --------------------------------

In the two column results, the left column gives the raw count and right column gives the percentage. \*100th percentile is the best among structures of comparable resolution; 0th percentile is the worst.

It is an evidentiary fact that XPA's and XPE's PPIs, in relation to one another, determine the NER's outcome, which is the removal of the DNA lesions from the genome.^[@ref42]^ The in vivo/in vitro binding mechanism of XPA to XPE exclusively studied by Wakasugi and his team was able to decipher the binding site of XPA through its interaction with XPE, yet their interactions at the molecular level are not known. So, to understand the molecular-level PPI interactions between these two proteins, we docked the modeled structure of XPA~185--226~ with XPE using a ClusPro server. The 10 model structures that we obtained from ClusPro have been shown in Supporting Information [Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf) along with the ranking based on the cluster numbers, center score, and their lowest energy weighted scores. In this study, we have selected the centers (model structures) from the clusters of size greater than or equal to 100 and having the lowest energy scores. On the basis of these selection criteria, we could select only three top-ranked structures for our study, which we named as models 1, 2, and 3. Model 1 represented the cluster of 181 members, with a cluster center score of −849.6 kcal mol^--1^ and the lowest energy score of −1104.3 kcal mol^--1^. Model 2 was clustered from 123 cluster members, with the cluster center and lowest energy scores of −952.3 and −1067.5 kcal mol^--1^, respectively. Similarly, model 3 represents the cluster of 111 members, with the cluster center and lowest energy scores of −859.3 and −1041.45 kcal mol^--1^, respectively. [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} shows the docking procedure as well as the surface and the cartoon structure for our complexes. We observed that in all three cases, XPA~185--226~ was bound to XPE at the cleft within the residues at the N- terminal and the C-terminal. The surface view of the docked complex shows the closely bound nature of the complex for all models. As seen from [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, the N-terminal end of XPA~185--226~ in models 1 and 3 was facing upward, whereas the C-terminal end was positioned downward, but in the case of model 2, it was just the opposite. Hence, to investigate the proper orientation of XPA's binding characteristics, we had performed MD simulation on all three models.

![Molecular docking of XPA~185--226~ and XPE.](ao-2018-017938_0001){#fig1}

2.2. Interpretations of the MD Trajectories for the XPA~185--226~--XPE Complex {#sec2.2}
------------------------------------------------------------------------------

The molecular dynamics simulation was administered to probe the structural and conformational changes affecting the PPI between XPA~185--226~ and XPE in an explicit environment. The MD trajectories of 40 ns simulation for all of the models were extracted with PTRAJ (short for Process TRAJectory) and CPPTRAJ (a rewrite of PTRAJ in C++) modules as a function of time. The stability of our systems was assessed by measuring the root RMSD of all Cα atoms from their initial coordinates. The RMSD plot for all models of the XPA~185--226~--XPE complex is given in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. The Cα atoms of model 1 initially fluctuated from 3 to 15 Å for a period of 15 ns, after which it started to settle. Models 2 and 3, on the other hand, started settling after 20 ns. Model 3 settled faster than the other two models.

![RMSD plot of Cα carbon atoms of XPA~185--226~--XPE complex as a function of time.](ao-2018-017938_0002){#fig2}

Since the solvent accessible surface area (SASA) of any protein--protein complex (PPC) is often associated with the number of hydrophobic contacts between a solvent and a protein, and since the proteins participating in a PPI are characterized by a larger accessible surface area,^[@ref52]^ we also examined the SASA feature for our complex. We found the SASA value for all of the models of XPA~185--226~--XPE complexes to be within 24 000--25 000 Å^2^ (see [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), which suggests a stable interaction.

![SASA plot for XPA~185--226~--XPE complex as a function of time.](ao-2018-017938_0003){#fig3}

To get a better insight into the RMSD changes, we next extracted the conformational snapshots of our systems at an interval of 10 ns each with respect to its equilibrated structure. [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} shows the trajectory snapshots for all three models of the XPA~185--226~--XPE complex showing its conformational and structural changes at 0, 10, 20, 30, and 40 ns. Here, we observed XPA~185--226~ peptide of all models to have exhibited secondary structural changes mainly at the helices. One striking feature of XPA as seen from [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} was the change in its orientation, where the N-terminal region, which was initially positioned upward in the case of models 1 and 3, had changed its position by almost 180° and was now at the bottom position, meaning that the C-terminal regions were now at the top. But in the case of model 2, XPA~185--226~ peptide retained its original position, showing changes only in its secondary structural elements. These changes can be observed in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, where the end terminal residues of XPA~185--226~ have been labeled to highlight the shift in XPA~185--226~'s orientation throughout the simulation. XPE, on the other hand, exhibited the conformational changes restricted only to its C-terminal end, which was stretched slightly from its original position. This may be to place XPA to conduct PPI necessary to regulate NER. The structural changes on the stretched end of XPE fluctuated in between coils and helix, where helix was the most dominant secondary structural element. The remaining structure of XPE showed no significant changes, maintaining its original β-sheet and the coil form.

![Conformational snapshots of XPA~185--226~--XPE complex at different time intervals.](ao-2018-017938_0004){#fig4}

To gain more insights into the binding between XPA and XPE, we also docked the redefined DBD region of XPA (aa98--239) with XPE to see whether they showed any similarity to these models of XPA--XPE complex or not. We conducted MD simulation for the same, during which we could observe that XPA~98--239~ was bound to XPE in the same fashion as model 1 of the XPA~185--226~--XPE complex from the above scenario. The C-terminal residues of XPA~98--239~ were seen to be at the top position, whereas the N-terminal residues were at the bottom ([Figure S4A,B](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf)). This orientation of XPA~98--239~ was retained throughout the simulation process, which further means that the conformational changes undergone by XPA~185--226~ in the case of models 1 and 3 with regard to their orientation are indeed concurrent with findings from the binding position of model 2's XPA~185--226~ and DBD region of XPA to XPE (N-terminal end toward bottom and C-terminal end at the top).

Next, we set to analyze the intermolecular hydrogen between XPA and XPE since it is a known fact that the hydrogen bonds provide molecular stability to the PPIs. The hydrogen bond analyses of the XPA~185--226~--XPE systems for the 40 ns simulation period are provided in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}. Models 1 and 2 exhibited a total of 20 intermolecular hydrogen bonds, with an average of 15--17 hydrogen bonds, whereas model 3 had total 15 hydrogen bonds with an average of 13--14 hydrogen bonds that were all within the ideal bond length and bond angles as demonstrated earlier.^[@ref53]^ The hydrogen bond occupancies of this complex are accordingly given in Supporting Information [Table S1A--C](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf).

![Intermolecular hydrogen bond analyses of XPA~185--226~--XPE complex as a function of time.](ao-2018-017938_0005){#fig5}

2.3. Protein--Protein Interface Characterization {#sec2.3}
------------------------------------------------

PPCs/PPIs of any living system is usually characterized by the presence of an interface area having a high number of hydrophobic interactions and a large solvent accessible surface area.^[@ref54]−[@ref56]^ The interface residues of any PPC are further characterized by their contact distance, which should be less than 6 Å from its interacting partner proteins.^[@ref57]^ So, to study the PPI between XPA~185--226~ and XPE, we employed the Dimplot program on the PDBsum server to help us identify and characterize the interface residues present in the lowest energy conformer of our protein complex.

The cartoon representation of our lowest energy conformer for all of the models can be seen in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A,C,E. The interface statistics for our protein complex is shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, while all of the residue interactions for our PPI present within this range (less than 6 Å) can be seen in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B,D,F, and the detailed contributions of each residue required in forming our stable PPC are accordingly provided in Supporting Information [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf). We obtained 22 residues of XPE with an interface area of 1171 Å^2^ to be interacting with 19 residues of XPA~185--226~ having an interface surface area of 1124 Å^2^. Likewise, models 2 and 3 had interface residues of 18 and 20 each for XPE with interface areas of 870 and 1116 Å^2^, respectively. XPA~185--226~ of models 2 and 3 were observed to have interface residues of 18 and 22 with interface areas of 867 and 1074 Å^2^, respectively. The number of hydrogen bonds, salt bridges, and hydrophobic contacts as seen in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} were more or less the same for all models.

![(A) Cartoon representation and (B) intermolecular interactions between model 1 of XPA~185--226~--XPE complex. (C) Cartoon representation and (D) intermolecular interactions between model 2 of XPA~185--226~--XPE complex. (E) Cartoon representation and (F) intermolecular interactions between model 3 of XPA~185--226~--XPE complex.](ao-2018-017938_0006){#fig6}

###### Interface Statistics for XPA~185--226~--XPE Protein Complex

  models          protein   no. of interface residues   interface area (Å^2^)   no. of salt bridges   no. of hydrogen bonds   no. of nonbonded contacts
  --------------- --------- --------------------------- ----------------------- --------------------- ----------------------- ---------------------------
  model 1         XPE       22                          1171                    7                     20                      147
  XPA~185--226~   19        1124                                                                                              
  model 2         XPE       18                          870                     8                     17                      141
  XPA~185--226~   18        867                                                                                               
  model 3         XPE       20                          1116                    9                     16                      140
  XPA~185--226~   22        1074                                                                                              

The PPIs of any PPCs can be classified into transient or permanent interactions based on their interface area, the charges carried by the interacting residues,^[@ref56],[@ref58],[@ref59]^ and the number of hydrogen bonds and salt bridge formations.^[@ref60]^ Since the interface size of an individual protein to form the PPC was less than 1500 Å^2^ for all of the models and has the presence of polar charged residues, the interaction between XPA and XPE can be termed as the strong transient PPI (TPPI).

From [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}, we can see that the most common residues of XPE to be involved in this strong TPPI among all three models were mainly Arg20, Arg47, Asp51, and Leu57. The common residues of XPA~185--226~ responsible for the interaction among three models were Leu191, Gln192, Val193, Trp194, Glu198, Glu202, Glu205, Arg207, Glu209, Gln216, and Phe219. The residue of XPA, R207, which upon mutation to glycine (R207G) had resulted in the inhibition of the XPA--XPE binding in an earlier study,^[@ref42]^ was seen to be involved in the PPI with XPE in all three cases. R207 of model 1's XPA formed a hydrophobic contact with Cys364 of XPE, whereas R207 of models 2 and 3 was seen to have interacted with Asp49 of XPE by forming a salt bridge, hydrophobic contact, and hydrogen bond. This means that R207 is very crucial for the binding of XPA and XPE. This particular residue has also been stated to be important for the XPA--DNA interaction,^[@ref61]^ and if mutated to other residues, it could lead to severe neurological impairment and cancer.^[@ref62],[@ref63]^ Q208, which reportedly causes classical XP-A phenotype upon mutation,^[@ref64]^ was seen to have interacted with four residues of XPE in the case of model 1 and five residues of XPE in the case of model 3, but showed no signs of PPI in model 3. Q208 also has recently been found to be involved in the DNA binding upon the NMR chemical shift perturbation (CSP) assay on the DBD of XPA by Sugitani and the group.^[@ref30]^ The same study had also found the weak DNA-binding activity of XPA upon the mutation of residue L191V, which in this study was common to all models for conducting the intermolecular interaction with XPE, further affirming its importance to the functioning of XPE in terms of PPI in the working of NER.

Additionally, we had also done PPI profile study between DBD of XPA (aa98--239) and XPE to see whether they showed any interactions or not. We extracted the lowest energy conformer of this complex from the highly populated clusters using RMSD clustering algorithm and then submitted this structure to the PDBsum server for PPI analysis. From the results obtained, we observed that the residues ranging between aa98--184 were not involved in the PPI between XPA and XPE and only the residues between aa185--226 were seen to participate in the PPI between the two proteins. The detailed results of these analyses can be found in the Supporting Information ([Figure S4C and Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf)). This further proves that XPA~185--226~ is the main driving force behind the binding of XPA and XPE and their interaction, which is again in agreement with Wakasugi's findings.

2.4. Decomposing the Free-Energy Contributions to the Binding Free Energy (BFE) of XPA~185--226~ and XPE on a Per-Residue Basis {#sec2.4}
-------------------------------------------------------------------------------------------------------------------------------

The estimation of a binding free energy (BFE) and its per-residue energy decomposition (PRED) between two or more systems reflects the binding mechanisms of that particular set of systems, whether it is a protein--protein or a protein--ligand or a DNA--protein system.^[@ref65],[@ref66]^ BFE and PRED studies have been extensively used in deciphering the crucial amino acid residues that contribute greatly to the PPI, drug--protein interactions.^[@ref67],[@ref68]^

To gain insights into the contribution of the individual amino acid residues to the overall PPI of XPA--XPE complex, PRED values were calculated using MM-PBSA module of the AMBER 14 software package. MM-PBSA uses a continuum solvent approach to determine the binding free energies of a system. The PRED results for all of the interface residues present in our complex are given in [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}A,B, and Supporting Information [Table S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf). R20, R47, and L57 were the common residues to have exhibited the highest PRED values for all three models. The highest energy contributions for XPA~185--226~ come from the residues L191, V193, W194, E198, E202, E205, R207, and F219 in all the three models. R207 from XPA and R20 from XPE had the highest energy decomposition rates for XPA~185--226~--XPE complex among all of the models, as seen from [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. The energy contribution of R207 is fairly reflective of its effect on XPA--XPE binding and can also be accounted for its role in the DNA binding where R207Q mutant was reported to have lowered the DNA-binding efficacy of XPA.^[@ref30]^ The decomposition energy yielded by F219 may also be related to its association with XPE as well as with the DNA, since the protein truncation of XPA at F219 position decreased the DNA-binding activity of XPA.^[@ref29]^

![Per-residue energy decomposition (PRED) plots for the interface residues of (A) XPA~185--226~ and (B) XPE.](ao-2018-017938_0007){#fig7}

The PRED values of each residue in any PPI/PPC have been known to contribute to the overall BFE of that particular protein complex. Hence, to address the stability of our models, we had also calculated the BFE of XPA~185--226~--XPE complex for all three models. The individual contribution of XPA~185--226~ and XPE to the complex formation is given in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. The tabulated ΔΔ*G*~binding~ using the PB method for models 1, 2, and 3 were found to be −48.3718, −49.09, and −56.51 kcal mol^--1^, respectively. This BFE can be very well accorded with their electrostatic and polar solvation energies.

###### Binding Free Energy (BFE) Analysis of XPA~185--226~--XPE Complex[a](#t3fn1){ref-type="table-fn"}

  method       models       components   XPA~185--226~--XPE protein complex (kcal mol^--1^)   XPA~185--226~ (kcal mol^--1^)   XPE (kcal mol^--1^)   ΔΔ*G*~bind~ (kcal mol^--1^)
  ------------ ------------ ------------ ---------------------------------------------------- ------------------------------- --------------------- -----------------------------
  MM-PBSA      model 1      Δ*E*~vdW~    --3316.62                                            --237.46                        --3028.03             --50.55
  Δ*E*~ele~    --29076.55   --2770.88    --25940.01                                           --365.65                                              
  Δ*E*~MM~     --32393.17   --3008.35    --28968.61                                           --416.21                                              
  Δ*G*~PB~     --6524.36    --1475.01    --5426.65                                            377.30                                                
  Δ*G*~surf~   173.33       32.01        150.78                                               --9.46                                                
  Δ*G*~solv~   --6351.02    --1442.99    --5275.86                                            367.84                                                
  PB~tot~      --38744.20   --4451.35    --34244.48                                           --48.37                                               
  model 2      Δ*E*~vdW~    --3381.81    --237.17                                             --3068.72                       --75.92               
  Δ*E*~ele~    --28929.58   --2908.32    --25414.01                                           --607.25                                              
  Δ*E*~MM~     --32311.40   --3145.49    --28482.73                                           --683.17                                              
  Δ*G*~PB~     --6299.89    --1345.77    --5535.91                                            581.79                                                
  Δ*G*~surf~   1483.35      88.80        1342.26                                              52.28                                                 
  Δ*G*~solv~   --4816.54    --1256.97    --4193.65                                            634.07                                                
  PB~tot~      --37127.94   --4402.46    --32676.38                                           --49.09                                               
  model 3      Δ*E*~vdW~    --3325.42    --240.45                                             --3009.43                       --75.53               
  Δ*E*~ele~    --28844.99   --2865.41    --25348.26                                           --631.31                                              
  Δ*E*~MM~     --32170.42   --3105.87    --28357.70                                           --706.85                                              
  Δ*G*~PB~     --6511.36    --1395.36    --5780.06                                            664.06                                                
  Δ*G*~surf~   168.38       31.15        150.94                                               --13.72                                               
  Δ*G*~solv~   --6342.97    --1364.20    --5629.11                                            650.33                                                
  PB~tot~      --38513.40   --4470.07    --33986.81                                           --56.51                                               

Δ*E*~ele~ = electrostatic energy as calculated by the MM force field; Δ*E*~vdW~ = van der Waals contribution from MM; Δ*E*~MM~ = total gas phase energy (sum of ele, vdW, and int); Δ*G*~PB~ = the electrostatic contribution to the polar solvation free energy calculated by PB; Δ*G*~surf~ = nonpolar contribution to the solvation free energy calculated by an empirical model; Δ*G*~sol~ = sum of nonpolar and polar contributions to solvation; PB~tot~ = final estimated binding free energy in kcal mol^--1^ calculated from the terms above.

3. Discussion {#sec3}
=============

PPIs are vital for all of the biological functions, whether it is signaling cascades, molecular switching, hormone receptor reactions,^[@ref56],[@ref58],[@ref59]^ or, in this case, a successful removal of the DNA lesion, triggered by ultraviolet radiations and anticancer agents. NER mechanism in a higher organism is rigorous and effective due to the numerous transient and permanent PPIs between various proteins, systematized largely by the XPA protein.^[@ref4],[@ref6]^ XPA, in particular, is recruited to the damage site upon its C-terminal interaction with p8 and p52 subunits of the TFIIH complex.^[@ref3],[@ref11],[@ref31]^ This happens simultaneously with the recruitment of RPA70 that protects the undamaged strand and stabilizes the NER bubble, wherein it also interacts with the DBD portion of XPA.^[@ref7],[@ref27],[@ref38]^ The N-terminal interaction of XPA (aa96--114) with the ERCC1 (aa92--119) is responsible for the recruitment of ERCC1/XPF complex, a structure-specific endonuclease to the damage site, which incises the lesion at 5′ end.^[@ref35]−[@ref37]^ Apart from these interactions, the accounts of many new interactions of XPA with other proteins have surfaced over the years. Reports of XPA's new binding partners, proliferating cell nuclear antigen (PCNA)^[@ref69]^ that is usually seen only during the ligation stage of NER, and two novel XPA-binding proteins (XAB), named XAB1,^[@ref70]^ and XAB2,^[@ref71]^ whose functions are not much known, suggest that XPA may play a much larger role in NER than just a mere damage verifier, and a scaffold protein.

The biochemical data provided by Wakasugi's team^[@ref42]^ on the XPA--DDB2/XPE interaction answered some of the questions surrounding XPA's scaffold nature. They were able to successfully demonstrate that XPA interacted with DDB1/DDB2 complex only through its DDB2 or XPE subunit under both in vivo and in vitro conditions, and not vice versa. They further went on to identify the exact binding region on XPA (aa185--226), which helped in establishing the PPI with XPE to conduct the NER process smoothly. Our in silico investigation on the probable PPI of human XPA~185--226~ with XPE using the information provided by Wakasugi et al. research findings showed that this interaction between XPA and XPE is stable. The results that we obtained from PDBsum server and SASA analysis suggested that this complex formation is of a strong transient PPI type, which is fairly justifiable considering that both proteins, especially XPA, are involved in forming various PPCs and PPIs with the repair proteins during the NER process, which is initiated within a fraction of seconds upon the damage detection and has to be quickly tended to. The protein--protein docking study and the analyses of the PPI profiles generated by PDBsum server for XPA--XPE complex revealed that among XPA~185--226~ and DBD of XPA (XPA~98--239~), the former length of the protein is responsible for the binding and interaction with XPE, whereas the XPA's residues before and after 185--226 in the case of XPA~98--239~--XPE complex were very much farther from XPE to create the intermolecular PPI. The PRED results also showed that XPA's region between 185--226 contains residues with high signatures of binding free energies, especially R207, which contributed greatly to their PPI and PPC formation. The observations made by Wakasugi and his team were also of a similar kind. They observed that the truncations up to 184 amino acids from the N-terminal of XPA showed no effect on the XPA--XPE binding, but even the slightest truncation of further 42 amino acids (XPA~185--226~) greatly diminished the interaction. Similar binding properties were obtained with purified DDB heterodimer, consistent with the notion that XPA binds to DDB heterodimer by interacting with DDB2. These results indicate that the amino-acid domain between 185 and 226 is required for the XPA--XPE/DDB2 interaction.

The significance of XPA~185--226~ is that the region which codes for this particular protein segment ranges from the terminal part of exon 4 through the whole part of exon 5 up to the beginning section of exon 6 in the XPA gene. This exons 4, 5, and 6 are responsible for coding the XPA's residues aa130--273, which is also the partial coding region for the DBD (aa130--239) of XPA. Therefore, any deletion within this section (exon 4--6) or the protein truncation at any position can not only inhibit the PPC formation between XPA and XPE but also lead to the collapsing of NER.^[@ref9],[@ref30]^ This binding region of XPA on XPE also coincides with the interaction sites for TFIIH^[@ref3],[@ref11],[@ref31]^ and with two NER-regulating proteins, ataxia telangiectasia and Rad3-related protein (ATR), which localizes XPA to the damage site by phosphorylating Ser196 in XPA,^[@ref72]^ and poly(ADP-ribose) polymerase 1 (PARP-1), which aids XPA in forming the preincision complex (PIC) in NER.^[@ref73]^ Our PRED analyses of the XPA's residues also shed light on the fact that the residues L191, R207, and F219 of XPA, which showed higher PRED values for PPI with XPE, have also been mentioned in the literature for playing a role in DNA interaction, PPI with other proteins, and in causing XP-A phenotypes upon mutations. The higher-energy decomposition values of these residues indicate their importance for XPA's functioning in NER.

Our present study has been able to shine light on one of the binding partners of XPA in terms of its scaffolding aspects, if not all. We hope that with increasing progress in the study of XPA, the day may come when all of the unsolved questions on XPA's role with different NER members (proteins and DNA) and its effect on NER outcomes and even the newly reported binding partners of XPA will finally be solved. The combination of structural, mechanistic, and dynamics data will prove to be the key elements in meeting this goal.

4. Conclusions {#sec4}
==============

In summary, our study has helped us determine the probable binding site of XPA~185--226~ on XPE and further characterize the interface residues that are responsible for their PPI. The structural and conformational dynamics study for all three models of the XPA~185--226~--XPE complex using all-atom MD simulations suggests that this interaction is stable and also of a strong transient type. The PRED analysis using MM-PBSA algorithm showed that the binding affinity between two proteins is indeed high, and their intermolecular PPI can be credited to the residues R20, R47, and L57 of XPE and the residues L191, V193, W194, E198, E202, E205, R207, and F219 of XPA.

5. Materials and Methodology {#sec5}
============================

5.1. Molecular Docking and the Preparation of Initial Structures {#sec5.1}
----------------------------------------------------------------

The three-dimensional structure of XPA~185--226~ was modeled by querying the desired protein sequence in Universal Protein Resource (UniProt) database^[@ref74]^ (ID: P23025), after which it was submitted to the I-TASSER server^[@ref75]^ that works on the protein threading and homology strategy for the structure prediction. Out of the five obtained structures from I-TASSER, we chose the best model based on the C-score, TM score,^[@ref76]^ and RMSD score. We then validated the fitness of the modeled structure using RAMPAGE server,^[@ref77]^ ProSA server,^[@ref78]^ and Molprobity sever.^[@ref79]^ For the structure of XPE, we retrieved the X-ray crystallized structure of the XPE/DDB1 heterodimer, which was in complex with DNA (PDB ID: 4E5Z)^[@ref80]^ from the Protein Data Bank,^[@ref81]^ and removed the DDB1 protein and DNA from the heterodimer complex using the University of California, San Francisco (UCSF) Chimera v.1.12,^[@ref82]^ retaining only XPE (DDB2) for further steps.

Next, we docked the best-represented structure of XPA~185--226~ with XPE using the ClusPro web server. This server, in particular, predicts an ideal docked conformation using three main strategies: (i) testing numerous conformations by fast Fourier transform-based rigid docking using PIPER algorithm, wherein the ligand is rotated 70 000 times, and each rotation places the ligand in *x*, *y*, *z* axis relative to the receptor on a grid, after which the best score of each rotation is chosen for further testing; (ii) of the 70 000 rotations, 1000 ligands/conformers are chosen based on their lowest energy scores, and (iii) 1000 conformers are clustered with 9 Å Cα RMSD radius to represent the most favorable conformer of the complex from their respective highly populated clusters, which means that the conformer having maximum neighbor within 9 Å is chosen as the cluster center, while its neighbors, which become part of that particular cluster, are later removed to retain only one conformer (cluster center) to represent that cluster. This is repeated for all of the clusters. Finally, the 10 such cluster center conformers obtained from the populated clusters are energy-minimized for 300 steps with fixed backbone using CHARMM (Chemistry at HARvard Macromolecular Mechanics) force field. The 10 model complexes (cluster centers) generated for the XPA~185--226~--XPE complex were ranked based on the number of highly populated clusters, cluster center, and the lowest energy weighted scores, out of which we chose top three models for our study.

Using Amberff99 force field,^[@ref83]^ we prepared the initial coordinate and the topology file for the chosen docked model of XPA~185--226~--XPE in the Leap module of the AMBER 14 software package.^[@ref46]^ The whole system was hydrated with water molecules (model 1 = 16 879, model 2 = 18 699, model 3 = 17 382) in a cuboid box with a buffer distance of 10 Å using the TIP3P (transferable intermolecular potential with 3 points) water model,^[@ref84]^ and was added with charge-balancing counterions (17 Cl^--^ ions each for all models) to neutralize the system.

5.2. MD Simulation of XPA~185--226~--XPE Complex {#sec5.2}
------------------------------------------------

MD study of our three systems/models was done in AMBER 14 suite using the particle mesh Ewald (PME) algorithm,^[@ref85]^ where the Leap prepared system was subjected to a two-step energy minimization first with a nonbonded interaction cutoff of 8 Å. The initial minimization was done using the steepest descent algorithm by imposing restraints over the solute, while the second conjugate gradient minimization method was done without any such restraints. The heating dynamics of the systems were done by gradually increasing the temperature from 0 to 300 K under constant volume (NVT) conditions, followed by the equilibration at NPT conditions. Full long-range MD production runs (40 ns) were done for the equilibrated structure of all of the models using the PME algorithm.^[@ref85]^ The Berendsen weak coupling algorithm^[@ref86]^ (0.5 ps of heat bath and 0.2 ps of pressure relaxation) was employed to control the temperature throughout the simulation process. The SHAKE algorithm^[@ref87]^ was used to restrain all of the bonds at the time step of 2 fs.

5.3. MD Analyses {#sec5.3}
----------------

The corresponding MD trajectories (40 ns each) obtained by simulating the three models of the XPA~185--226~--XPE complexes were analyzed using PTRAJ and CPPTRAJ algorithms.^[@ref88]^ Further, we also determined the intermolecular hydrogen bonds formed between XPA~185--226~ and XPE in all of the systems. The result were drawn based on the bond occupancy, bond length (cutoff = 3 Å), and bond angle (cutoff = 135°) formed (HA--H--HD) between the hydrogen donor (HD) and the hydrogen acceptor (HA) atoms of both proteins. The molecular graphics, visualization, and analyses of all MD snapshots were performed using UCSF Chimera package v.1.12.

5.4. Determination of the Interface Residues {#sec5.4}
--------------------------------------------

The lowest energy conformers of the XPA~185--226~--XPE complex for all three models were extracted from the highly populated cluster using RMSD clustering algorithm. The generated structures were then uploaded to the PDBsum server^[@ref89]^ for the determination of the intermolecular interactions of all of the models.

5.5. PRED and BFE Analyses of XPA~185--226~--XPE Complex {#sec5.5}
--------------------------------------------------------

The relative binding free energy (BFE) and the per-residue energy decomposition (PRED) of the interface residues of the protein complex in this present study were obtained using MMPBSA.py script of the AMBER 14 suite based on the MM-PBSA algorithm.^[@ref47]−[@ref51],[@ref65],[@ref66]^ The PRED analysis breaks down the energy contributed by each residue of a protein by studying its molecular interactions over all residues in the system/complex. The MM-PBSA analysis was conducted for all three models of XPA~185--226~--XPE using the following components: (i) XPA~185--226~ (ligand), (ii) XPE (receptor), and (iii) XPA~185--226~--XPE (complex), by taking full 40 ns MD trajectories into account.

The free energy of XPA~ligand~ + XPE~receptor~ = XPA--XPE~complex~ was calculated using the following equations derived from the second law of thermodynamics, where they were studied in both gas (vacuum) and aqueous environments.Here, *G*~binding~ is the total binding free energy and *G*~complex~, *G*~receptor~, and *G*~ligand~ are the relative free energies of the XPA~185--226~--XPE, XPE, and XPA~185--226,~ respectively. The free energy (*G*) for each component can be obtained by adding the sum of changes in the gas-phase molecular mechanics energies (Δ*E*~MM~), polar and nonpolar solvation energy (Δ*G*~solvation~), and conformational entropy (−*T*Δ*S*) of the system (see [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}).where *E*~MM~ from [eq [3](#eq3){ref-type="disp-formula"}](#eq3){ref-type="disp-formula"} is the difference in the internal energy (*E*~internal~), van der Waals forces (*E*~vdW~), and electrostatic energy (*E*~ele~). The solvation free energy, *G*~solvation~, as seen from [eq [4](#eq4){ref-type="disp-formula"}](#eq4){ref-type="disp-formula"} was calculated as the sum of the polar contribution (*G*~PB~) and nonpolar contribution (*G*~surf~). Thus, the free energy of any system can also be explained as the sum of molecular mechanics, solvation free energy, and conformational entropies (see [eq [5](#eq5){ref-type="disp-formula"}](#eq5){ref-type="disp-formula"}).

Using PB solver of the AMBER 14 pbsa module,^[@ref90]^ the polar solvation energies were determined for the complex. The probe radius and the grid space for our estimation were set to 1.4 and 0.5 Å, respectively. We maintained the dielectric constant of the interior (solvent) and external (solute) as 80 and 1, respectively. Using the solvent accessible surface area (SASA), the nonpolar contribution (*G*~surf~) to the solvation free energy was calculated (see [eq [6](#eq6){ref-type="disp-formula"}](#eq6){ref-type="disp-formula"}). The nonpolar solvation energy for PB method was obtained by taking γ = 0.00542 kcal mol^--1^ Å^--2^ and β = 0.92 kcal mol^--1^.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b01793](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b01793).Top five models generated for XPA~185--226~ by I-TASSER server (Figure S1); structure validation of the modeled XPA~185--226~: (A) Ramachandran plot as obtained from Rampage server and (B) Z-score plot energy plot as determined by the ProSA-web server (Figure S2); top 10 representative docked models for XPA~185--226~--XPE complex generated by ClusPro server along with their rankings based on the highly populated cluster numbers and their lowest energy weighted scores (Figure S3); cartoon representation of the XPA~98--239~--XPE complex at (A) 0 ns and (B) 40 ns; (C) intermolecular interactions between XPA~98--239~--XPE complex (Figure S4); (A) intermolecular hydrogen bond occupancy for model 1 of XPA~185--226~--XPE complex, (B) intermolecular hydrogen bond occupancy for model 2 of XPA~185--226~--XPE complex, and (C) intermolecular hydrogen bond occupancy for model 3 XPA~185--226~--XPE complex (Table S1); intermolecular interactions across XPA~185--226~--XPE interface; (A) intermolecular hydrogen bond between XPA~185--226~ and XPE protein complex, (B) intermolecular salt bridge formation between XPA~185--226~ and XPE protein complex, and (C) intermolecular nonbonded contacts formed between XPA~185--226~ and XPE protein complex (Table S2); (A) interface statistics for XPA~98--239~--XPE protein complex, (B) intermolecular hydrogen bond between XPA~98--239~ and XPE protein complex, (C) intermolecular salt bridge formation between XPA~98--239~ and XPE protein complex, and (D) intermolecular nonbonded contacts formed between XPA~98--239~ and XPE protein complex (Table S3); per-residue energy decomposition (PRED) analysis of the interface residues of XPA~185--226~--XPE complex (Table S4) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01793/suppl_file/ao8b01793_si_001.pdf))
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:   assisted model building with energy refinement
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:   ataxia telangiectasia and Rad3-related protein
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CPPTRAJ

:   a rewrite of PTRAJ in C++

CSP

:   chemical shift perturbation

DBD

:   DNA-binding domain

DDB2/XPE

:   damaged DNA-binding protein 2

DNA

:   deoxyribonucleic acid

ERCC1/XPF

:   excision-repair cross-complementing group 1 endonuclease (*Xeroderma pigmentosum* group F)

GG-NER
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MD
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PARP-1

:   poly(ADP-ribose) polymerase 1
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:   proliferating cell nuclear antigen

PIC
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PME

:   particle mesh Ewald

PPC

:   protein--protein complex

PPI

:   protein--protein interactions

PRED
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ProSA
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SV40
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TFIIH
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TIP3P
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:   template modeling

TPPI
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XAB
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XPA
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XPC
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:   *Xeroderma pigmentosum* complementation group E
